Work

Abstract CT161: A phase II clinical trial of lurbinectedin in patients with advanced gastrointestinal malignancies with DNA repair mutations

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct161

Authors: Alexa F. Viniotis, Gayle S. Jameson, Betsy C. Wertheim, Denise J. Roe, Daniel Mocan, Shelby Pearse, Sunil Sharma, Michael S. Gordon, Daniel D. Von Hoff, Erkut H. Borazanci

Institutions: HonorHealth, University of Arizona, University of Arizona Cancer Center, Translational Genomics Research Institute

Language: English

Topic: Genetic factors in colorectal cancer

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154754516

Cites:

Cited by:

Related to: